{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:08:35Z","timestamp":1777936115753,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43710-6","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:53:03Z","timestamp":1773679983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Splice-site mutations in POU2AF1 are associated with B-cell lymphomagenesis and therapeutic response"],"prefix":"10.1038","volume":"16","author":[{"given":"Natalia","family":"Yanguas-Cas\u00e1s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Horcajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagrario","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aranzazu","family":"Garcia-Grande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Mu\u00f1oz-Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Fern\u00e1ndez-Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"P\u00e9rez-Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Torres-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Rodr\u00edguez-Perales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"S\u00e1nchez-Beato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"2","key":"43710_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3960\/jslrt.56.79","volume":"56","author":"K Miyazaki","year":"2016","unstructured":"Miyazaki, K. Treatment of Diffuse Large B-Cell Lymphoma. J. Clin. Exp. Hematop JCEH. 56 (2), 79\u201388 (2016).","journal-title":"J. Clin. Exp. Hematop JCEH"},{"issue":"6769","key":"43710_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (6769), 503\u2013511 (2000).","journal-title":"Nature"},{"key":"43710_CR3","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/s41598-020-80376-0","volume":"11","author":"L Pedrosa","year":"2021","unstructured":"Pedrosa, L. et al. Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma. Sci. Rep. 11, 1886 (2021).","journal-title":"Sci. Rep."},{"issue":"20","key":"43710_CR4","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood.2019003535","volume":"135","author":"SE Lacy","year":"2020","unstructured":"Lacy, S. E. et al. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood 135 (20), 1759\u20131771 (2020).","journal-title":"Blood"},{"issue":"4","key":"43710_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright, G. W. et al. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. Cancer Cell. 37 (4), 551\u2013568e14 (2020).","journal-title":"Cancer Cell."},{"issue":"5","key":"43710_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy, B. et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat. Med. 24 (5), 679\u2013690 (2018).","journal-title":"Nat. Med."},{"issue":"17","key":"43710_CR7","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1182\/blood-2015-11-624288","volume":"127","author":"BS Kahl","year":"2016","unstructured":"Kahl, B. S. & Yang, D. T. Follicular lymphoma: evolving therapeutic strategies. Blood 127 (17), 2055\u20132063 (2016).","journal-title":"Blood"},{"issue":"1","key":"43710_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1182\/asheducation-2016.1.366","volume":"2016","author":"B Coiffier","year":"2016","unstructured":"Coiffier, B. & Sarkozy, C. Diffuse large B-cell lymphoma: R-CHOP failure\u2014what to do? Hematol. Am. Soc. Hematol. Educ. Program. 2016 (1), 366\u2013378 (2016).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"issue":"9","key":"43710_CR9","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1093\/annonc\/mdx189","volume":"28","author":"C Casulo","year":"2017","unstructured":"Casulo, C., Nastoupil, L., Fowler, N. H., Friedberg, J. W. & Flowers, C. R. Unmet needs in the first-line treatment of follicular lymphoma. Ann. Oncol. 28 (9), 2094\u20132106 (2017).","journal-title":"Ann. Oncol."},{"issue":"1","key":"43710_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/imr.12755","volume":"288","author":"C Mlynarczyk","year":"2019","unstructured":"Mlynarczyk, C., Font\u00e1n, L. & Melnick, A. Germinal center-derived lymphomas: The darkest side of humoral immunity. Immunol. Rev. 288 (1), 214\u2013239 (2019).","journal-title":"Immunol. Rev."},{"issue":"9","key":"43710_CR11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41590-018-0181-4","volume":"19","author":"P Milpied","year":"2018","unstructured":"Milpied, P. et al. Human germinal center transcriptional programs are de-synchronized in B cell lymphoma. Nat. Immunol. 19 (9), 1013\u20131024 (2018).","journal-title":"Nat. Immunol."},{"key":"43710_CR12","doi-asserted-by":"publisher","first-page":"597651","DOI":"10.3389\/fimmu.2021.597651","volume":"12","author":"L Ysebaert","year":"2021","unstructured":"Ysebaert, L. et al. Lymphoma Heterogeneity Unraveled by Single-Cell Transcriptomics. Front. Immunol. 12, 597651 (2021).","journal-title":"Front. Immunol."},{"issue":"4","key":"43710_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","volume":"5","author":"R K\u00fcppers","year":"2005","unstructured":"K\u00fcppers, R. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer. 5 (4), 251\u2013262 (2005).","journal-title":"Nat. Rev. Cancer"},{"issue":"20","key":"43710_CR14","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127 (20), 2375\u20132390 (2016).","journal-title":"Blood"},{"issue":"1","key":"43710_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.beha.2017.10.006","volume":"31","author":"T Lackraj","year":"2018","unstructured":"Lackraj, T., Goswami, R. & Kridel, R. Pathogenesis of follicular lymphoma. Best Pract. Res. Clin. Haematol. 31 (1), 2\u201314 (2018).","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"43710_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","volume":"40","author":"GD Victora","year":"2022","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal Centers. Annu. Rev. Immunol. 40, 413\u2013442 (2022).","journal-title":"Annu. Rev. Immunol."},{"key":"43710_CR17","doi-asserted-by":"publisher","first-page":"1125503","DOI":"10.3389\/fimmu.2023.1125503","volume":"14","author":"AC Betzler","year":"2023","unstructured":"Betzler, A. C., Ushmorov, A. & Brunner, C. The transcriptional program during germinal center reaction - a close view at GC B cells, Tfh cells and Tfr cells. Front. Immunol. 14, 1125503 (2023).","journal-title":"Front. Immunol."},{"issue":"12","key":"43710_CR18","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1158\/1541-7786.MCR-22-0567","volume":"20","author":"T McLachlan","year":"2022","unstructured":"McLachlan, T. et al. B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers. Mol. Cancer Res. 20 (12), 1711\u20131723 (2022).","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"43710_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/path.4446","volume":"235","author":"MJ Moreno","year":"2015","unstructured":"Moreno, M. J. et al. CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival. J. Pathol. 235 (3), 445\u2013455 (2015).","journal-title":"J. Pathol."},{"key":"43710_CR20","doi-asserted-by":"publisher","first-page":"591577","DOI":"10.3389\/fonc.2020.591577","volume":"10","author":"L Ondrisova","year":"2020","unstructured":"Ondrisova, L. & Mraz, M. Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies. Front. Oncol. 10, 591577 (2020).","journal-title":"Front. Oncol."},{"key":"43710_CR21","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3389\/fimmu.2018.01313","volume":"9","author":"TS Weber","year":"2018","unstructured":"Weber, T. S. Cell Cycle-Associated CXCR4 Expression in Germinal Center B Cells and Its Implications on Affinity Maturation. Front. Immunol. 9, 1313 (2018).","journal-title":"Front. Immunol."},{"issue":"8","key":"43710_CR22","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s41375-019-0392-1","volume":"33","author":"L Herviou","year":"2019","unstructured":"Herviou, L., Jourdan, M., Martinez, A. M., Cavalli, G. & Moreaux, J. EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation. Leukemia 33 (8), 2047\u20132060 (2019).","journal-title":"Leukemia"},{"issue":"3","key":"43710_CR23","first-page":"1039","volume":"200","author":"M Guo","year":"2018","unstructured":"Guo, M. et al. EZH2 represses the B cell transcriptional program and regulates antibody secreting cell metabolism and antibody production. J. Immunol. Baltim. Md. 1950. 200 (3), 1039\u20131052 (2018).","journal-title":"J. Immunol. Baltim. Md. 1950"},{"issue":"4","key":"43710_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-020-00446-2","volume":"21","author":"BJ Laidlaw","year":"2021","unstructured":"Laidlaw, B. J. & Cyster, J. G. Transcriptional regulation of memory B cell differentiation. Nat. Rev. Immunol. 21 (4), 209\u2013220 (2021).","journal-title":"Nat. Rev. Immunol."},{"issue":"14","key":"43710_CR25","doi-asserted-by":"publisher","first-page":"E2039","DOI":"10.1073\/pnas.1600557113","volume":"113","author":"DJ Hodson","year":"2016","unstructured":"Hodson, D. J. et al. Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2. Proc. Natl. Acad. Sci. U S A. 113 (14), E2039\u2013E2046 (2016).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"7","key":"43710_CR26","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/modpathol.3800622","volume":"19","author":"RC McCune","year":"2006","unstructured":"McCune, R. C., Syrbu, S. I. & Vasef, M. A. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas: a comparative study using high throughput tissue microarrays. Mod. Pathol. 19 (7), 1010\u20131018 (2006).","journal-title":"Mod. Pathol."},{"issue":"5","key":"43710_CR27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1309\/YCH8DWUFFQBKGPVB","volume":"120","author":"P Browne","year":"2003","unstructured":"Browne, P., Petrosyan, K., Hernandez, A. & Chan, J. A. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Am. J. Clin. Pathol. 120 (5), 767\u2013777 (2003).","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"43710_CR28","first-page":"211","volume":"15","author":"AI S\u00e1ez","year":"2002","unstructured":"S\u00e1ez, A. I. et al. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1\/OBF.1 in lymphomas. Mod. Pathol. Off J. U S Can. Acad. Pathol. Inc. 15 (3), 211\u2013220 (2002).","journal-title":"Mod. Pathol. Off J. U S Can. Acad. Pathol. Inc"},{"issue":"3","key":"43710_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/eji.202149333","volume":"52","author":"AC Betzler","year":"2022","unstructured":"Betzler, A. C. et al. BOB.1\/OBF.1 is required during B-cell ontogeny for B-cell differentiation and germinal center function. Eur. J. Immunol. 52 (3), 404\u2013417 (2022).","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"43710_CR30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0002-9440(10)63882-5","volume":"162","author":"T Marafioti","year":"2003","unstructured":"Marafioti, T. et al. Expression of B-Lymphocyte-Associated Transcription Factors in Human T-Cell Neoplasms. Am. J. Pathol. 162 (3), 861\u2013871 (2003).","journal-title":"Am. J. Pathol."},{"issue":"6","key":"43710_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1182\/blood.2022018719","volume":"142","author":"K Dreval","year":"2023","unstructured":"Dreval, K. et al. Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns. Blood 142 (6), 561\u2013573 (2023).","journal-title":"Blood"},{"issue":"12","key":"43710_CR32","doi-asserted-by":"publisher","first-page":"e1002197","DOI":"10.1371\/journal.pmed.1002197","volume":"13","author":"R Kridel","year":"2016","unstructured":"Kridel, R. et al. Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study. PLoS Med. 13 (12), e1002197 (2016).","journal-title":"PLoS Med."},{"issue":"4","key":"43710_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/hon.3132","volume":"41","author":"P Mozas","year":"2023","unstructured":"Mozas, P. et al. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors. Hematol. Oncol. 41 (4), 631\u2013643 (2023).","journal-title":"Hematol. Oncol."},{"issue":"4","key":"43710_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1182\/blood-2016-07-729954","volume":"129","author":"K Krysiak","year":"2017","unstructured":"Krysiak, K. et al. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood 129 (4), 473\u2013483 (2017).","journal-title":"Blood"},{"issue":"2","key":"43710_CR35","doi-asserted-by":"publisher","first-page":"e0212813","DOI":"10.1371\/journal.pone.0212813","volume":"14","author":"J Gonz\u00e1lez-Rinc\u00f3n","year":"2019","unstructured":"Gonz\u00e1lez-Rinc\u00f3n, J. et al. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma. PloS One. 14 (2), e0212813 (2019).","journal-title":"PloS One"},{"issue":"1","key":"43710_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41525-021-00197-6","volume":"6","author":"RI Juul","year":"2021","unstructured":"Juul, R. I., Nielsen, M. M., Juul, M., Feuerbach, L. & Pedersen, J. S. The landscape and driver potential of site-specific hotspots across cancer genomes. NPJ Genomic Med. 6 (1), 33 (2021).","journal-title":"NPJ Genomic Med."},{"key":"43710_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.biomaterials.2015.09.007","volume":"73","author":"YF Tian","year":"2015","unstructured":"Tian, Y. F. et al. Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells. Biomaterials 73, 110\u2013119 (2015).","journal-title":"Biomaterials"},{"issue":"3","key":"43710_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan, K. et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell 176 (3), 535\u2013548e24 (2019).","journal-title":"Cell"},{"issue":"1","key":"43710_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13059-022-02664-4","volume":"23","author":"T Zeng","year":"2022","unstructured":"Zeng, T. & Li, Y. I. Predicting RNA splicing from DNA sequence using Pangolin. Genome Biol. 23 (1), 103 (2022).","journal-title":"Genome Biol."},{"issue":"12","key":"43710_CR40","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","volume":"109","author":"V Pejaver","year":"2022","unstructured":"Pejaver, V. et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria. Am. J. Hum. Genet. 109 (12), 2163\u20132177 (2022).","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"43710_CR41","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 (3), 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"issue":"43","key":"43710_CR42","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. 102 (43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"20","key":"43710_CR43","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1182\/blood-2011-03-344374","volume":"118","author":"C G\u00f3mez-Abad","year":"2011","unstructured":"G\u00f3mez-Abad, C. et al. PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma. Blood 118 (20), 5517\u20135527 (2011).","journal-title":"Blood"},{"key":"43710_CR44","unstructured":"Kolde, R. pheatmap: Pretty Heatmaps [Internet]. 2019 [cited 2024 July 4]. Available from: https:\/\/cran.r-project.org\/web\/packages\/pheatmap\/index.html"},{"key":"43710_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biomaterials.2018.06.034","volume":"198","author":"A Purwada","year":"2019","unstructured":"Purwada, A. et al. Ex vivo synthetic immune tissues with T cell signals for differentiating antigen-specific, high affinity germinal center B cells. Biomaterials 198, 27\u201336 (2019).","journal-title":"Biomaterials"},{"issue":"7","key":"43710_CR46","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 9 (7), 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"issue":"88","key":"43710_CR47","first-page":"e51046","volume":"1","author":"CR Justus","year":"2014","unstructured":"Justus, C. R., Leffler, N., Ruiz-Echevarria, M. & Yang, L. V. In vitro Cell Migration and Invasion Assays. JoVE J. Vis. Exp. 1 (88), e51046 (2014).","journal-title":"JoVE J. Vis. Exp."},{"issue":"7","key":"43710_CR48","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nmeth.4346","volume":"14","author":"J Lever","year":"2017","unstructured":"Lever, J., Krzywinski, M. & Altman, N. Principal component analysis. Nat. Methods. 14 (7), 641\u2013642 (2017).","journal-title":"Nat. Methods"},{"issue":"1","key":"43710_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1158\/1078-0432.CCR-22-1654","volume":"29","author":"I Fern\u00e1ndez-Miranda","year":"2023","unstructured":"Fern\u00e1ndez-Miranda, I. et al. Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study. Clin. Cancer Res. Off J. Am. Assoc. Cancer Res. 29 (1), 209\u2013220 (2023).","journal-title":"Clin. Cancer Res. Off J. Am. Assoc. Cancer Res."},{"key":"43710_CR50","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Miranda, I. et al. Generation and external validation of a histological transformation risk model for patients with follicular lymphoma. Mod. Pathol. Off J. U S Can. Acad. Pathol. Inc ;100516. (2024).","DOI":"10.1016\/j.modpat.2024.100516"},{"issue":"6","key":"43710_CR51","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ccr.2012.05.024","volume":"21","author":"Y Yang","year":"2012","unstructured":"Yang, Y. et al. Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma. Cancer Cell. 21 (6), 723\u2013737 (2012).","journal-title":"Cancer Cell."},{"issue":"34","key":"43710_CR52","doi-asserted-by":"publisher","first-page":"16981","DOI":"10.1073\/pnas.1905239116","volume":"116","author":"C Scuoppo","year":"2019","unstructured":"Scuoppo, C. et al. Repurposing dasatinib for diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. U S A. 116 (34), 16981\u201316986 (2019).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"7","key":"43710_CR53","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.cell.2016.04.044","volume":"165","author":"T Mikuni","year":"2016","unstructured":"Mikuni, T. et al. High-Resolution Mapping of Protein Localization in Mammalian Brain by In Vivo Genome Editing. Cell 165 (7), 1803\u20131817 (2016).","journal-title":"Cell"},{"issue":"21","key":"43710_CR54","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1091\/mbc.e17-03-0209","volume":"28","author":"B Roberts","year":"2017","unstructured":"Roberts, B. et al. Systematic gene tagging using CRISPR\/Cas9 in human stem cells to illuminate cell organization. Mol. Biol. Cell. 28 (21), 2854\u20132874 (2017).","journal-title":"Mol. Biol. Cell."},{"key":"43710_CR55","doi-asserted-by":"crossref","unstructured":"Fang, H., Bygrave, A. M., Roth, R. H., Johnson, R. C. & Huganir, R. L. An optimized CRISPR\/Cas9 approach for precise genome editing in neurons. Day JJ, Chen L, Choquet D, editors. eLife. ;10:e65202. (2021).","DOI":"10.7554\/eLife.65202"},{"issue":"6585","key":"43710_CR56","doi-asserted-by":"publisher","first-page":"eabi6983","DOI":"10.1126\/science.abi6983","volume":"375","author":"NH Cho","year":"2022","unstructured":"Cho, N. H. et al. OpenCell: Endogenous tagging for the cartography of human cellular organization. Science 375 (6585), eabi6983 (2022).","journal-title":"Science"},{"issue":"8","key":"43710_CR57","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.ccell.2024.06.006","volume":"42","author":"T He","year":"2024","unstructured":"He, T. et al. Targeting the mSWI\/SNF complex in POU2F-POU2AF transcription factor-driven malignancies. Cancer Cell. 42 (8), 1336\u20131351e9 (2024).","journal-title":"Cancer Cell."},{"issue":"7","key":"43710_CR58","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41590-021-00936-y","volume":"22","author":"D Chen","year":"2021","unstructured":"Chen, D. et al. Coupled analysis of transcriptome and BCR mutations reveals role of OXPHOS in affinity maturation. Nat. Immunol. 22 (7), 904\u2013913 (2021).","journal-title":"Nat. Immunol."},{"issue":"6","key":"43710_CR59","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1002\/hon.70001","volume":"42","author":"M Kedmi","year":"2024","unstructured":"Kedmi, M. et al. Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed\/Refractory Aggressive B-Cell Lymphoma. Hematol. Oncol. 42 (6), e70001 (2024).","journal-title":"Hematol. Oncol."},{"issue":"1","key":"43710_CR60","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12288-021-01433-w","volume":"38","author":"L Ren","year":"2022","unstructured":"Ren, L. et al. Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study. Indian J. Hematol. Blood Transfus. 38 (1), 42\u201350 (2022).","journal-title":"Indian J. Hematol. Blood Transfus."},{"issue":"22","key":"43710_CR61","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.1182\/bloodadvances.2023011400","volume":"7","author":"N Schmitz","year":"2023","unstructured":"Schmitz, N. & Karsten, I. E. Ibrutinib in the treatment of relapsed FL and MZL? Blood Adv. 7 (22), 7139\u20137140 (2023).","journal-title":"Blood Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43710-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:19:56Z","timestamp":1777691996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43710-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43710"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43710-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"13656"}}